HR 1829 · 117th Congress · Health

Pharmacy Benefit Manager Accountability Study Act of 2021

Introduced 2021-03-11· Sponsored by Rep. Harshbarger, Diana [R-TN-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2021-03-12)

Plain Language Summary

[AI summary unavailable — showing source text] Pharmacy Benefit Manager Accountability Study Act of 2021 This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

3 Democrats17 Republicans
Rep. Carter, Earl L. "Buddy" [R-GA-1]GA
Rep. Van Drew, Jefferson [R-NJ-2]NJ
Rep. Carl, Jerry L. [R-AL-1]AL
Rep. Keller, Fred [R-PA-12]PA
Rep. Griffith, H. Morgan [R-VA-9]VA
Rep. Posey, Bill [R-FL-8]FL
Rep. Axne, Cynthia [D-IA-3]IA
Rep. Welch, Peter [D-VT-At Large]VT
Rep. Spartz, Victoria [R-IN-5]IN
Rep. Guest, Michael [R-MS-3]MS
Rep. Murphy, Gregory [R-NC-3]NC
Rep. Miller-Meeks, Mariannette [R-IA-2]IA
Rep. Rosendale Sr., Matthew M. [R-MT-At Large]MT
Rep. Chabot, Steve [R-OH-1]OH
Rep. Cohen, Steve [D-TN-9]TN
Rep. Grothman, Glenn [R-WI-6]WI
Rep. Thompson, Glenn [R-PA-15]PA
Rep. Perry, Scott [R-PA-10]PA
Rep. Miller, Mary E. [R-IL-15]IL
Rep. Norman, Ralph [R-SC-5]SC